Modi, A.
Sen, S.
Adachi, J. D.
Adami, S.
Cortet, B.
Cooper, A. L.
Geusens, P.
Mellström, D.
Weaver, J. P.
van den Bergh, J. P.
Keown, P.
Sajjan, S.
Funding for this research was provided by:
Merck
Article History
Received: 22 March 2017
Accepted: 12 October 2017
First Online: 6 November 2017
Compliance with ethical standards
: The study was performed in accordance with the Declaration of Helsinki and either the local ethics board or a central institutional review board. All participants provided written informed consent prior to enrollment.
: A. Modi and S. Sen are employees of Merck & Co., Inc. and own stock in the company. J.D. Adachi has received grant support and speaker honorarium from Actavis, Amgen, Eli Lilly, Merck & Co., Inc. and Novartis. J.D. Adachi is a consultant for Amgen, Eli Lilly, and Merck & Co., Inc. S. Adami has received consulting honorarium from Merck & Co., Inc. and served as a board member for Merck & Co., Inc. B. Cortet has received research grants, consulting honorarium, and/or speaker honorarium from Amgen, Expanscience, Ferring, Eli Lilly, Merck & Co., Inc., Merck Sharp & Dohme, Medtronic, and Roche diagnostics. A.L. Cooper has received research grants, advisory board and/or speaker honorarium from Consilient Health and Internis Pharmaceuticals. P. Geusens has received research grants, advisory board and/or speaker honorarium from Pfizer, Abbott, Eli Lilly, Amgen, Merck Sharp & Dohme, Will Pharma, Roche, UCB pharmaceuticals, Bristol-Myers Squibb, and Novaritis. D.Mellström has received consulting honorarium from Merck Sharp & Dohme. J.P. Weaver is an employee of Merck & Co., Inc. J.P. van den Bergh is a paid consultant at Amgen and Will Pharma. J.P. van den Bergh has received research grants and speaker honorarium from Amgen, Will Pharma, and Eli Lilly. P.A. Keown is the director of and employed by Syreon Corporation and has received financial remuneration from Merck & Co., Inc. to conduct the study, participate in study meetings, and perform statistical analysis. S. Sajjan was an employee of Merck & Co., Inc. and owned stock in the company at the time of the study.